Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05142241 |
|---|---|
| Brief Title: | Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial |
| First Submitted : | December 1, 2021 |
| First Submitted that Met QC Criteria : | December 1, 2021 |
| First Posted : | December 2, 2021 |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 22, 2024 |